BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33000397)

  • 1. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
    Xu B; Peng F; Tang W; Du Y; Guo H
    Ann Pharmacother; 2016 Sep; 50(9):697-705. PubMed ID: 27317015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter ablation for paroxysmal and persistent atrial fibrillation.
    Chen HS; Wen JM; Wu SN; Liu JP
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007101. PubMed ID: 22513945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials.
    Shi LZ; Heng R; Liu SM; Leng FY
    Exp Ther Med; 2015 Aug; 10(2):816-822. PubMed ID: 26622399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.
    Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.
    Chen C; Zhou X; Zhu M; Chen S; Chen J; Cai H; Dai J; Xu X; Mao W
    J Interv Card Electrophysiol; 2018 Jun; 52(1):9-18. PubMed ID: 29549512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Turagam MK; Garg J; Whang W; Sartori S; Koruth JS; Miller MA; Langan N; Sofi A; Gomes A; Choudry S; Dukkipati SR; Reddy VY
    Ann Intern Med; 2019 Jan; 170(1):41-50. PubMed ID: 30583296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term and long-term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis.
    Liu Z; Yang Z; Lu Y; Wang H; Zou C
    Clin Cardiol; 2023 Oct; 46(10):1146-1153. PubMed ID: 37469293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
    Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.
    Pappone C; Rosanio S; Augello G; Gallus G; Vicedomini G; Mazzone P; Gulletta S; Gugliotta F; Pappone A; Santinelli V; Tortoriello V; Sala S; Zangrillo A; Crescenzi G; Benussi S; Alfieri O
    J Am Coll Cardiol; 2003 Jul; 42(2):185-97. PubMed ID: 12875749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.